Bal Pharma — 360° view

Bal Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹90 crore and net profit of ₹1.43 crore for the September 2026 quarter.

Bal Pharma (NSE: BALPHARMA-BE) closed at ₹83.21 on 20 Nov 2026. Its market capitalisation is ₹132 crore and it trades at 16.7 times earnings.

Share price
₹83.21 (20 Nov 2026)
Market cap
₹132 Cr (20 Nov 2026)
P/E
16.74 (20 Nov 2026)
Revenue
₹90 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
9.75% (FY26)
ROE
7.79% (FY26)
Book value
₹54.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹99.00 / ₹77.60 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: BALPHARMA-BE

Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.